J Korean Med Sci. 2017 Jan;32(1):1-3. English.
Published online Nov 28, 2016.
© 2017 The Korean Academy of Medical Sciences.
Brief Communication

Atypical Neonatal Marfan Syndrome with p.Glu1073Lys Mutation of FBN1: the First Case in Korea

Ju Sun Heo,1 Joo Young Song,1 Eun Young Choi,2 Eun-Hee Kim,1 Ji Hee Kim,1 So Eun Park,1 and Ji-Hyun Jeon1
    • 1Department of Pediatrics, CHA Gangnam Medical Center, CHA University, Seoul, Korea.
    • 2Department of Pediatrics, Sejong General Hospital, Bucheon, Korea.
Received June 25, 2016; Accepted October 04, 2016.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Neonatal Marfan syndrome (nMFS) is considered to be on the most severe end of the spectrum of type I fibrillinopathies. The common features of nMFS include ascending aortic dilatation, severe mitral and/or tricuspid valve insufficiency, ectopia lentis, arachnodactyly, joint contractures, crumpled ear, loose skin, and pulmonary emphysema.We describe a newborn male diagnosed with nMFS. He presented several atypical features, such as diaphragmatic eventration, severe hydronephrosis with hydroureter, and dilated cisterna magna. Molecular analysis revealed a missense mutation at nucleotide 3217 (c.3217G>A) in exon 26 of the fibrillin-1 (FBN1) gene, resulting in the substitution of a glutamate for a lysine at codon 1073 (E1073K) in the 12th calcium binding epidermal growth factor-like domain of the FBN1 protein. Here we report a rare case of Nmfs with several combined atypical features, such as diaphragmatic eventration, severe hydronephrosis with hydroureter, and dilated cisterna magna. Our report is the first atypical nMFS case with p.Glu1073Lys mutation of FBN1 in Korea and may help clinicians with the diagnosis and follow-up of atypical nMFS.

Graphical Abstract

Keywords
Marfan Syndrome; Neonate; Diaphragmatic Eventration; Hydronephrosis; Cisterna Magna

In July 2015, a male newborn was born vaginally at 36+5 weeks gestation to a G1P0 mother. The birth weight was 3,000 g (75th to 90th percentile), birth length was 54.5 cm (> 99th percentile), and head circumference was 35.5 cm (99th percentile). Physical examination revealed several dysmorphic features, such as facial dysmorphism with dolichocephaly, micro- and retrognathia, downslanting palpebral fissures, crumpled ears, marked arachnodactyly, an adducted thumb, reduced elbow extension and pectus excavatum. In ophthalmological investigation, no lens dislocation was noted. Echocardiography showed a dilated aortic root (aortic sinus diameter 14.9 mm, z-score 4.5) (Fig. 1A), mild aortic regurgitation, and redundant mitral valve chordae apparatus. The abdominal ultrasonography revealed grade 4 hydronephrosis and severe hydroureter in the right kidney (Fig. 1B). Brain magnetic resonance imaging confirmed a dilated cisterna magna, particularly on the left (Fig. 1C). In spine ultrasonography, no dural ectasia was noted. Chest radiography showed eventration of the right hemidiaphragm (Fig. 1D). Weak diaphragmatic motion and shallow excursion during respiration in the right hemidiaphragm were confirmed by dynamic thoracic ultrasonography (Fig. 1E).The systemic score was 6 points. Direct sequencing was performed for a total of 65 exons of the fibrillin-1 (FBN1) gene. The analysis revealed missense mutation at nucleotide 3217 (c.3217G>A) in exon 26 of the FBN1 gene, resulting in the substitution of a glutamate for a lysine at codon 1073 (p.Glu1073Lys) in the 12th calcium binding epidermal growth factor-like domain of the FBN1 protein. At 6 months of age, abrupt cardiac arrest caused by rupture of mitral chordae occurred, and surgical repair was conducted. He was prescribed captopril and is on follow-up. There were no abnormally tall relatives in the family and no family history of cardiac, ophthalmic, or genetic disease.

Fig. 1
Images from echocardiography, renal ultrasonography, brain magnetic resonance imaging, chest radiography, and dynamic thoracic ultrasonography.
(A) Dilated aortic root (aortic sinus diameter 14.9 mm, z-score 4.5). (B) Gr 4 hydronephrosis and hydroureter on the right. (C) Dilated cisterna magna on the left. (D) Eventration of the right hemidiaphragm. (E) Weak diaphragmatic motion and shallow excursion on the right during respiration.

Marfan syndrome (MFS, OMIM: 154700) is a disorder of the connective tissue with autosomal dominant inheritance and is caused by mutations in the gene coding for FBN1, located on chromosome 15q21.1 (1). Significant phenotypic variability of MFS is commonly observed and neonatal MFS (nMFS) is the severe end of clinical spectrum of MFS, with death often occurring within the first 2 years of life due to congestive heart failure (2, 3, 4). And this severe, early-lethal manifestation has been correlated with mutations in exons 24–32 (3). The common features of nMFS include ascending aortic dilatation, severe mitral and/or tricuspid valve insufficiency, ectopia lentis, arachnodactyly, crumpled ear, and pulmonary emphysema (4, 5). To our knowledge, there have been 2 nMFS cases to date in the literature with identical mutations to the present case (6, 7). All the cases, including the present case, had severe cardiovascular abnormalities and common features like congenital contracture, arachnodactyly and crumpled ear. However, there were no patients other than the present case who had several atypical manifestations, such as diaphragmatic eventration, severe hydronephrosis with hydroureter, and dilated cisterna magna. Our report is the first atypical nMFS case with p.Glu1073Lys mutation of FBN1 in Korea and may help clinicians with the diagnosis and follow-up of atypical nMFS.

ACKNOWLEDGMENT

The authors thank the patient and parents for participation in the genetic study. The genetic study was performed at the Department of Laboratory Medicine and Genetics, Samsung Medical Center.

References

    1. von Kodolitsch Y, De Backer J, Schüler H, Bannas P, Behzadi C, Bernhardt AM, Hillebrand M, Fuisting B, Sheikhzadeh S, Rybczynski M, et al. Perspectives on the revised Ghent criteria for the diagnosis of Marfan syndrome. Appl Clin Genet 2015;8:137–155.
    1. Robinson PN, Arteaga-Solis E, Baldock C, Collod-Béroud G, Booms P, De Paepe A, Dietz HC, Guo G, Handford PA, Judge DP, et al. The molecular genetics of Marfan syndrome and related disorders. J Med Genet 2006;43:769–787.
    1. Mizuguchi T, Matsumoto N. Recent progress in genetics of Marfan syndrome and Marfan-associated disorders. J Hum Genet 2007;52:1–12.
    1. Hennekam RC. Severe infantile Marfan syndrome versus neonatal Marfan syndrome. Am J Med Genet A 2005;139:1.
    1. Faivre L, Masurel-Paulet A, Collod-Béroud G, Callewaert BL, Child AH, Stheneur C, Binquet C, Gautier E, Chevallier B, Huet F, et al. Clinical and molecular study of 320 children with Marfan syndrome and related type I fibrillinopathies in a series of 1009 probands with pathogenic FBN1 mutations. Pediatrics 2009;123:391–398.
    1. Nijbroek G, Sood S, McIntosh I, Francomano CA, Bull E, Pereira L, Ramirez F, Pyeritz RE, Dietz HC. Fifteen novel FBN1 mutations causing Marfan syndrome detected by heteroduplex analysis of genomic amplicons. Am J Hum Genet 1995;57:8–21.
    1. Putnam EA, Cho M, Zinn AB, Towbin JA, Byers PH, Milewicz DM. Delineation of the Marfan phenotype associated with mutations in exons 23-32 of the FBN1 gene. Am J Med Genet 1996;62:233–242.

Metrics
Share
Figures

1 / 1

PERMALINK